Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 4
2022 10
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC.
Borghetti P, Imbrescia J, Volpi G, Scotti V, Aquilano M, Bruni A, Franceschini D, Ursino S, Ciammella P, Piperno G, Taraborrelli M, Magrini SM. Borghetti P, et al. Among authors: volpi g. Radiat Oncol. 2022 Jul 16;17(1):124. doi: 10.1186/s13014-022-02084-5. Radiat Oncol. 2022. PMID: 35842660 Free PMC article.
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy.
Guerini AE, Filippi AR, Tucci A, Simontacchi G, Re A, Guaineri A, Morelli V, Borghetti P, Triggiani L, Pegurri L, Pedretti S, Volpi G, Spiazzi L, Magrini SM, Buglione M. Guerini AE, et al. Among authors: volpi g. Clin Lymphoma Myeloma Leuk. 2022 Feb;22(2):e135-e148. doi: 10.1016/j.clml.2021.09.005. Epub 2021 Sep 10. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34728169 Review.
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience.
Borghetti P, Volpi G, Facheris G, Cossali G, Mataj E, La Mattina S, Singh N, Imbrescia J, Bonù ML, Tomasini D, Vitali P, Greco D, Bezzi M, Melotti F, Benvenuti M, Borghesi A, Grisanti S, Buglione di Monale E Bastia M. Borghetti P, et al. Among authors: volpi g. Front Oncol. 2023 Jul 4;13:1208204. doi: 10.3389/fonc.2023.1208204. eCollection 2023. Front Oncol. 2023. PMID: 37469420 Free PMC article.
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study.
Borghetti P, Branz J, Volpi G, Pancera S, Buraschi R, Bianchi LNC, Bonù ML, Greco D, Facheris G, Tomasi C, Pini L, Bezzi M, Grisanti S, Gallazzi MS, Borghesi A, Buglione di Monale E Bastia M; ASST Spedali Civili of Brescia Lung Unit. Borghetti P, et al. Among authors: volpi g. Radiol Med. 2022 Dec;127(12):1322-1332. doi: 10.1007/s11547-022-01562-w. Epub 2022 Oct 10. Radiol Med. 2022. PMID: 36217071 Free PMC article.
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy.
Borghetti P, Toraci C, Imbrescia J, Volpi G, Lucchini S, Guerini AE, Magli A, Spiazzi L, Reginelli A, Cappabianca S, Magrini SM, Nardone V. Borghetti P, et al. Among authors: volpi g. Ann Nucl Med. 2021 Oct;35(10):1174-1176. doi: 10.1007/s12149-021-01662-z. Epub 2021 Jul 28. Ann Nucl Med. 2021. PMID: 34322785 Free PMC article. No abstract available.
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial.
Magrini SM, Tomasini D, Focà E, Garrafa EM, Singh N, Guerini AE, Triggiani L, Bresciani R, Greco D, Pegurri L, LA Mattina S, Ranghetti E, Volpi G, Maroldi R, Buglione M, Spiazzi L. Magrini SM, et al. Among authors: volpi g. In Vivo. 2022 Jul-Aug;36(4):1959-1965. doi: 10.21873/invivo.12918. In Vivo. 2022. PMID: 35738608 Free PMC article.
16 results